Estudio del dolor tras la administración subcutánea de diferentes preparaciones de eritropoyetina humana recombinante
J. L. Teruel, A. Aguilera y J. Ortuño.
Leído
6227
Vecesse ha leído el artículo
4550
Total PDF
1677
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 55 | 61 | 116 |
| 2025 5 | 45 | 109 | 154 |
| 2025 4 | 31 | 62 | 93 |
| 2025 3 | 49 | 109 | 158 |
| 2025 2 | 37 | 72 | 109 |
| 2025 1 | 39 | 65 | 104 |
| 2024 12 | 21 | 67 | 88 |
| 2024 11 | 30 | 67 | 97 |
| 2024 10 | 29 | 80 | 109 |
| 2024 9 | 27 | 88 | 115 |
| 2024 8 | 28 | 102 | 130 |
| 2024 7 | 46 | 89 | 135 |
| 2024 6 | 28 | 85 | 113 |
| 2024 5 | 32 | 75 | 107 |
| 2024 4 | 55 | 76 | 131 |
| 2024 3 | 48 | 60 | 108 |
| 2024 2 | 32 | 91 | 123 |
| 2024 1 | 16 | 51 | 67 |
| 2023 12 | 11 | 81 | 92 |
| 2023 11 | 17 | 80 | 97 |
| 2023 10 | 18 | 131 | 149 |
| 2023 9 | 9 | 83 | 92 |
| 2023 8 | 14 | 95 | 109 |
| 2023 7 | 23 | 101 | 124 |
| 2023 6 | 14 | 90 | 104 |
| 2023 5 | 16 | 112 | 128 |
| 2023 4 | 11 | 90 | 101 |
| 2023 3 | 9 | 71 | 80 |
| 2023 2 | 8 | 67 | 75 |
| 2022 1 | 13 | 72 | 85 |
| 2022 12 | 18 | 61 | 79 |
| 2022 11 | 18 | 76 | 94 |
| 2022 10 | 21 | 78 | 99 |
| 2022 9 | 17 | 57 | 74 |
| 2022 8 | 21 | 88 | 109 |
| 2022 7 | 14 | 129 | 143 |
| 2022 6 | 12 | 111 | 123 |
| 2022 5 | 10 | 93 | 103 |
| 2022 4 | 16 | 123 | 139 |
| 2022 3 | 15 | 87 | 102 |
| 2022 2 | 12 | 90 | 102 |
| 2021 1 | 11 | 86 | 97 |
| 2021 12 | 12 | 90 | 102 |
| 2021 11 | 11 | 76 | 87 |
| 2021 10 | 8 | 92 | 100 |
| 2021 9 | 17 | 74 | 91 |
| 2021 8 | 10 | 61 | 71 |
| 2021 7 | 11 | 48 | 59 |
| 2021 6 | 4 | 30 | 34 |
| 2021 5 | 9 | 29 | 38 |
| 2021 4 | 9 | 55 | 64 |
| 2021 3 | 9 | 26 | 35 |
| 2021 2 | 14 | 39 | 53 |
| 2020 1 | 5 | 31 | 36 |
| 2020 12 | 8 | 19 | 27 |
| 2020 11 | 6 | 8 | 14 |
| 2020 10 | 13 | 5 | 18 |
| 2020 9 | 5 | 8 | 13 |
| 2020 8 | 13 | 7 | 20 |
| 2020 7 | 8 | 11 | 19 |
| 2020 6 | 7 | 8 | 15 |
| 2020 5 | 9 | 10 | 19 |
| 2020 4 | 11 | 8 | 19 |
| 2020 3 | 10 | 4 | 14 |
| 2020 2 | 26 | 19 | 45 |
| 2020 1 | 19 | 18 | 37 |
| 2019 12 | 11 | 17 | 28 |
| 2019 11 | 7 | 4 | 11 |
| 2019 10 | 9 | 0 | 9 |
| 2019 9 | 12 | 21 | 33 |
| 2019 8 | 5 | 9 | 14 |
| 2019 7 | 11 | 15 | 26 |
| 2019 6 | 2 | 4 | 6 |
| 2019 5 | 8 | 26 | 34 |
| 2019 4 | 34 | 38 | 72 |
| 2019 3 | 6 | 7 | 13 |
| 2019 2 | 12 | 14 | 26 |
| 2019 1 | 3 | 5 | 8 |
| 2018 12 | 11 | 15 | 26 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 1 | 1 | 2 |
| 2018 9 | 4 | 0 | 4 |
| 2018 8 | 7 | 4 | 11 |
| 2018 7 | 10 | 1 | 11 |
| 2018 6 | 3 | 0 | 3 |
| 2018 5 | 2 | 0 | 2 |
| 2018 4 | 3 | 0 | 3 |
| 2018 3 | 4 | 0 | 4 |
| 2018 2 | 1 | 0 | 1 |
| 2017 12 | 2 | 0 | 2 |
| 2017 11 | 5 | 1 | 6 |
| 2017 10 | 1 | 0 | 1 |
| 2017 9 | 1 | 0 | 1 |
| 2017 8 | 2 | 0 | 2 |
| 2017 7 | 2 | 4 | 6 |
| 2017 5 | 6 | 1 | 7 |
| 2017 4 | 2 | 0 | 2 |
| 2017 3 | 5 | 17 | 22 |
| 2017 2 | 2 | 1 | 3 |
| 2016 1 | 3 | 1 | 4 |
| 2016 12 | 6 | 0 | 6 |
| 2016 11 | 12 | 1 | 13 |
| 2016 10 | 18 | 3 | 21 |
| 2016 9 | 7 | 3 | 10 |
| 2016 8 | 10 | 0 | 10 |
| 2016 7 | 2 | 0 | 2 |
| 2016 6 | 12 | 0 | 12 |
| 2016 5 | 16 | 0 | 16 |
| 2016 4 | 15 | 0 | 15 |
| 2016 3 | 13 | 0 | 13 |
| 2016 2 | 19 | 0 | 19 |
| 2015 1 | 1 | 0 | 1 |
| 2015 12 | 19 | 0 | 19 |
| 2015 11 | 9 | 0 | 9 |
| 2015 10 | 5 | 0 | 5 |
| 2015 9 | 3 | 0 | 3 |
| 2015 8 | 9 | 0 | 9 |
| 2015 7 | 18 | 0 | 18 |
| 2015 6 | 11 | 0 | 11 |
| 2015 5 | 22 | 0 | 22 |
Mostrar todo
